{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Premier, Inc. Experiences Revision in Its Stock Evaluation Amid Competitive Market Dynamics
Premier, Inc., a small-cap hospital industry player, has adjusted its valuation metrics, showing a P/E ratio of 14 and a notable dividend yield of 369.41%. While it has outperformed the S&P 500 over the past year, its longer-term performance reveals challenges compared to its peers.
Is Premier, Inc. overvalued or undervalued?
As of October 17, 2025, Premier, Inc. is considered overvalued with a P/E ratio of 14 and an EV to EBITDA of 13.73, despite a strong year-to-date return of 32.08%, due to its long-term decline of 20.05% over five years and higher valuation ratios compared to peers.
Is Premier, Inc. overvalued or undervalued?
As of October 17, 2025, Premier, Inc. is considered overvalued with a P/E ratio of 14 compared to peers, a low PEG ratio of 0.19, and a recent strong YTD return of 32.08%, but a poor long-term performance of -17.89% over three years, indicating a shift from attractive to very expensive.
Premier, Inc. Hits Day High with 9.71% Surge in Strong Intraday Performance
Premier, Inc., a small-cap hospital industry player, saw significant intraday activity, reaching a high of USD 28.35. The company has shown strong short-term performance, with notable gains over the past week and month, despite facing long-term growth challenges and declining net sales in recent years.
Is Premier, Inc. technically bullish or bearish?
As of September 8, 2025, Premier, Inc. shows a bullish technical trend with positive indicators like the weekly MACD and daily moving averages, despite mixed long-term performance compared to the S&P 500.
Is Premier, Inc. overvalued or undervalued?
As of July 7, 2025, Premier, Inc. is considered very expensive and overvalued with a P/E ratio of 14 and an EV to EBITDA of 13.73, significantly underperforming the S&P 500 with a 3-year return of -24.08% compared to 70.41%.
Is Premier, Inc. overvalued or undervalued?
As of April 24, 2025, Premier, Inc. is considered overvalued with a valuation grade of very expensive, reflected in its P/E ratio of 14 and lagging stock performance compared to the S&P 500, while its valuation metrics suggest a premium price relative to earnings growth potential.
Is Premier, Inc. technically bullish or bearish?
As of June 11, 2025, the trend is mildly bullish due to positive MACD and moving averages, but caution is advised due to a bearish weekly RSI and mixed signals from Dow Theory.
Who are in the management team of Premier, Inc.?
As of March 2022, the management team of Premier, Inc. includes Chairman Terry Shaw, CEO Susan DeVore, Lead Independent Director William Mayer, and Directors Barclay Berdan, Peter Fine, Marc Miller, and Marvin O'Quinn. They oversee the company's operations and strategic direction.
What does Premier, Inc. do?
Premier, Inc. is a healthcare improvement company focused on the hospital industry, with recent net sales of $261 million and a net profit of $28 million. It has a market cap of approximately $1.98 billion and key metrics include a P/E ratio of 14.00 and a dividend yield of 380.78%.
How big is Premier, Inc.?
As of Jun 24, Premier, Inc. has a market capitalization of 1,975.17 million, with net sales of 1,100.06 million and net profit of 115.31 million over the last four quarters. Shareholder's funds are 1,962.23 million, and total assets amount to 3,428.59 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
